Globus Medical Reports Third Quarter 2021 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/21/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall Street sinks as bond yields rise, Walmart results disappoint
- Supermicro probe finds no senior management link to export violations
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
Globus Medical (GMED) Tops Q3 EPS by 5c
November 4, 2021 5:10 PM EDTGlobus Medical (NYSE: GMED) reported Q3 EPS of $0.50, $0.05 better than the analyst estimate of $0.45. Revenue for the quarter came in at $229.7 million versus the consensus estimate of $228.31 million.
For earnings history and earnings-related data on Globus Medical (GMED) click here.
... More